D. Hadler

发表

A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease.

S. Hofmann, W. Herrmann, G. Weyer, 1997, Neuropsychobiology.

Idebenone: a guide to its use in Alzheimer’s disease, other age-related cognitive disorders and Friedreich’s ataxia

I. Deary, A. Gow, S. Noble, 2010 .

Alzheimer's Disease Assessment Scale: Reliability and Validity in a Multicenter Clinical Trial

R. Ihl, S. Kanowski, G. Weyer, 1997, International Psychogeriatrics.

Long‐Term Treatment of Severe Chronic Heart Failure with Captopril: A Double‐Blind, Randomized, Placebo‐Controlled, Long‐Term Study

W. Bussmann, M. Kaltenbach, N. Reifart, 1987, Journal of cardiovascular pharmacology.

Randomized, double‐blind, placebo‐controlled trial of the efficacy and tolerability of a new isoindoline derivative (DN‐2327) in generalized anxiety

S. Hofmann, M. Linden, D. Hadler, 1997 .

Aldosterone and prolactin responsiveness after prolonged treatment of congestive heart failure with captopril

W. Bussmann, M. Kaltenbach, D. Hadler, 2004, European Journal of Clinical Pharmacology.

A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer.

M. Krzakowski, J. von Pawel, R. Beckman, 2013, Lung cancer.

Plasma LPI in β-Thalassemia Patients before and after Treatment with Deferasirox (Exjade®, ICL670).

A. Taher, A. Pathare, S. Daar, 2005 .

Deferasirox (Exjade®, ICL670) Treatment of Inadequately Chelated β-Thalassemia Patients from the Middle East: The ESCALATOR Trial.

A. Taher, A. El‐Beshlawy, S. Daar, 2005 .

Efficacy and safety of idebenone in the long‐term treatment of Alzheimer's Disease: a double‐blind, placebo controlled multicentre study

G. Weyer, D. Hadler, H. Erzigkeit, 1996 .

Therapeutic drug monitoring of tacrine: simple and fast high-performance liquid chromatography assay method for its determination in human plasma.

G. Anderegg, D. Hadler, E. Castellà, 2000, Therapeutic drug monitoring.

Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug.

D. Hadler, M. Stark, K. Schaffler, 1998, Arzneimittel-Forschung.

Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.

M. Rapp, K. Kühl, D. Hadler, 2002, Pharmacopsychiatry.

Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study.

D. Hadler, H. Gutzmann, 1998, Journal of neural transmission. Supplementum.

Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.

M N Rossor, R J Harvey, S Shimohama, 1997, Alzheimer disease and associated disorders.